Chapter 1. Hereditary Testing Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Disease Type
1.1.1.2. Technology Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Hereditary Testing Market: Executive Summary
2.1. Market Snapshot
2.2. Disease Type Technology Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Hereditary Testing Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Increase in sales and demand for DNA test kits
3.4.2. Constantly developing commercial landscape of women's reproductive health
3.4.3. Decline in sequencing cost & consequent expansion of genetic testing registry
3.5. Market Restraint Analysis
3.5.1. Ethical and clinical issues of DNA tests
3.5.2. Regulatory challenges pertaining to use of DTC genetic tests
3.6. Market Opportunity Analysis
3.6.1. Increasing incidence of genetic diseases
3.6.2. Presence of demand for early and non-invasive fetal testing procedures
3.6.3. Introduction of fragmented point-solutions across the genomics value chain
3.7. Porter’s Five Forces Analysis
3.8. PESTLE Analysis
3.9. Pipeline Analysis
Chapter 4. Hereditary Testing Market: Disease Type Estimates & Trend Analysis
4.1. Hereditary Testing Market: Disease Type Movement Analysis
4.2. Hereditary Cancer Testing
4.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.2. Breast Cancer
4.2.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.3. Lung Cancer
4.2.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.4. Colorectal Cancer
4.2.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.5. Cervical Cancer
4.2.5.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.6. Ovarian Cancer
4.2.6.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.7. Prostate Cancer
4.2.7.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.8. Stomach/Gastric Cancer
4.2.8.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.9. Melanoma
4.2.9.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.10. Sarcoma
4.2.10.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.11. Uterine Cancer
4.2.11.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.12. Pancreatic Cancer
4.2.12.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.2.13. Others
4.2.13.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3. Hereditary Non-cancer Testing
4.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Genetic Tests
4.3.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2. Cardiac Diseases
4.3.2.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3. Rare Diseases
4.3.2.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.4. Other Diseases
4.3.2.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Preimplantation Genetic Diagnosis & Screening
4.3.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.4. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
4.3.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3.5. Newborn Genetic Screening
4.3.5.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Hereditary Testing Market: Technology Estimates & Trend Analysis
5.1. Hereditary Testing Market: Technology Movement Analysis
5.2. Cytogenetic
5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3. Biochemical
5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Molecular Testing
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Hereditary Testing Market: Regional Business Analysis
6.1. Regional Market Snapshot
6.2. North America
6.2.1. North America Hereditary Testing Market Estimates and Forecast, 2021-2033 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Hereditary Testing Market, 2021-2033 (USD Million)
6.2.2.2. Key Country Dynamics
6.2.2.3. Regulatory Framework
6.2.2.4. Reimbursement Scenario
6.2.2.5. Competitive Scenario
6.2.3. Canada
6.2.3.1. Canada Hereditary Testing Market, 2021-2033 (USD Million)
6.2.3.2. Key Country Dynamics
6.2.3.3. Regulatory Framework
6.2.3.4. Reimbursement Scenario
6.2.3.5. Competitive Scenario
6.2.4. Mexico
6.2.4.1. Mexico Hereditary Testing Market, 2021-2033 (USD Million)
6.2.4.2. Key Country Dynamics
6.2.4.3. Regulatory Framework
6.2.4.4. Reimbursement Scenario
6.2.4.5. Competitive Scenario
6.3. Europe
6.3.1. Europe Hereditary Testing Market, 2021-2033 (USD Million)
6.3.2. UK
6.3.2.1. UK Hereditary Testing Market, 2021-2033 (USD Million)
6.3.2.2. Key Country Dynamics
6.3.2.3. Regulatory Framework
6.3.2.4. Reimbursement Scenario
6.3.2.5. Competitive Scenario
6.3.3. Germany
6.3.3.1. Germany Hereditary Testing Market, 2021-2033 (USD Million)
6.3.3.2. Key Country Dynamics
6.3.3.3. Regulatory Framework
6.3.3.4. Reimbursement Scenario
6.3.3.5. Competitive Scenario
6.3.4. Spain
6.3.4.1. Spain Hereditary Testing Market, 2021-2033 (USD Million)
6.3.4.2. Key Country Dynamics
6.3.4.3. Regulatory Framework
6.3.4.4. Reimbursement Scenario
6.3.4.5. Competitive Scenario
6.3.5. France
6.3.5.1. France Hereditary Testing Market, 2021-2033 (USD Million)
6.3.5.2. Key Country Dynamics
6.3.5.3. Regulatory Framework
6.3.5.4. Reimbursement Scenario
6.3.5.5. Competitive Scenario
6.3.6. Italy
6.3.6.1. Italy Hereditary Testing Market, 2021-2033 (USD Million)
6.3.6.2. Key Country Dynamics
6.3.6.3. Regulatory Framework
6.3.6.4. Reimbursement Scenario
6.3.6.5. Competitive Scenario
6.3.7. Denmark
6.3.7.1. Denmark Hereditary Testing Market, 2021-2033 (USD Million)
6.3.7.2. Key Country Dynamics
6.3.7.3. Regulatory Framework
6.3.7.4. Reimbursement Scenario
6.3.7.5. Competitive Scenario
6.3.8. Sweden
6.3.8.1. Sweden Hereditary Testing Market, 2021-2033 (USD Million)
6.3.8.2. Key Country Dynamics
6.3.8.3. Regulatory Framework
6.3.8.4. Reimbursement Scenario
6.3.8.5. Competitive Scenario
6.3.9. Norway
6.3.9.1. Norway Hereditary Testing Market, 2021-2033 (USD Million)
6.3.9.2. Key Country Dynamics
6.3.9.3. Regulatory Framework
6.3.9.4. Reimbursement Scenario
6.3.9.5. Competitive Scenario
6.4. Asia-Pacific
6.4.1. Asia-Pacific Hereditary Testing Market, 2021-2033 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Hereditary Testing Market, 2021-2033 (USD Million)
6.4.2.2. Key Country Dynamics
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Scenario
6.4.2.5. Competitive Scenario
6.4.3. China
6.4.3.1. China Hereditary Testing Market, 2021-2033 (USD Million)
6.4.3.2. Key Country Dynamics
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Scenario
6.4.3.5. Competitive Scenario
6.4.4. India
6.4.4.1. India Hereditary Testing Market, 2021-2033 (USD Million)
6.4.4.2. Key Country Dynamics
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Scenario
6.4.4.5. Competitive Scenario
6.4.5. South Korea
6.4.5.1. South Korea Hereditary Testing Market, 2021-2033 (USD Million)
6.4.5.2. Key Country Dynamics
6.4.5.3. Regulatory Framework
6.4.5.4. Reimbursement Scenario
6.4.5.5. Competitive Scenario
6.4.6. Thailand
6.4.6.1. Thailand Hereditary Testing Market, 2021-2033 (USD Million)
6.4.6.2. Key Country Dynamics
6.4.6.3. Regulatory Framework
6.4.6.4. Reimbursement Scenario
6.4.6.5. Competitive Scenario
6.4.7. Australia
6.4.7.1. Australia Hereditary Testing Market, 2021-2033 (USD Million)
6.4.7.2. Key Country Dynamics
6.4.7.3. Regulatory Framework
6.4.7.4. Reimbursement Scenario
6.4.7.5. Competitive Scenario
6.5. Latin America
6.5.1. Latin America Hereditary Testing Market, 2021-2033 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Hereditary Testing Market, 2021-2033 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Competitive Scenario
6.5.3. Argentina
6.5.3.1. Argentina Hereditary Testing Market, 2021-2033 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Competitive Scenario
6.6. Middle East & Africa
6.6.1. Middle East & Africa Hereditary Testing Market, 2021-2033 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Hereditary Testing Market, 2021-2033 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. Competitive Scenario
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Hereditary Testing Market, 2021-2033 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Competitive Scenario
6.6.4. UAE
6.6.4.1. UAE Hereditary Testing Market, 2021-2033 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. Competitive Scenario
6.6.5. Kuwait
6.6.5.1. Kuwait Hereditary Testing Market, 2021-2033 (USD Million)
6.6.5.2. Key Country Dynamics
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Competitive Scenario
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. New Product Launch
7.2.2. Partnerships
7.2.3. Acquisition
7.2.4. Collaboration
7.2.5. Funding
7.3. Key Company Market Share Analysis, 2024
7.4. Company Heat Map Analysis
7.5. Company Profiles
7.5.1. Myriad Genetics, Inc.
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Invitae Corporation
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Illumina, Inc.
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Natera, Inc.
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Laboratory Corporation of America Holdings
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. F. Hoffmann-La Roche Ltd.
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Quest Diagnostics Incorporated
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. COOPERSURGICAL, INC.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Agilent Technologies, Inc.
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Thermo Fisher Scientific, Inc.
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. Twist Bioscience
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. SOPHiA GENETICS
7.5.12.1. Company Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. Fulgent Genetics
7.5.13.1. Company Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
7.5.14. MedGenome
7.5.14.1. Company Overview
7.5.14.2. Financial Performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic Initiatives
7.5.15. CENTOGENE N.V.
7.5.15.1. Company Overview
7.5.15.2. Financial Performance
7.5.15.3. Product Benchmarking
7.5.15.4. Strategic Initiatives
List of Tables
Table 1 Product mapping for hereditary cancer tests
Table 2 DNA sequencing costs over the past decade
Table 3 Global incidence rate of genetic disorders
Table 4 Technology landscape for NIPT tests
Table 5 Comparison of other technologies
Table 6 Countries that prescribe mandatory medical supervision & restriction for genetic tests
Table 7 Susceptibility genes and their prevalence in hereditary ovarian syndromes
Table 8 Various NGS tests for hereditary prostate cancer
Table 9 Genetic testing scenario for patients/families affected by inherited cardiac disease
Table 10 Financial solutions for PGT:
Table 11 Commercial landscape of NIPT for fetal aneuploidy in the U.S.
Table 12 North America hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 16 North America hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 17 U.S. hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 18 U.S. hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 19 Canada hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 20 Canada hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 21 Mexico hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 22 Mexico hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 23 Europe hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 35 Europe hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 36 UK hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 37 UK hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 38 Germany hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 39 Germany hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 40 France hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 41 France hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 42 Spain hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 43 Spain hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 43 Italy hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 44 Italy hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 45 Denmark hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 46 Denmark hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 47 Sweden hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 48 Sweden hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 49 Norway hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 50 Norway hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 51 Asia-Pacific hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 52 Asia-Pacific hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 53 China hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 54 China hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 55 Japan hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 56 Japan hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 57 India hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 58 India hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 59 South Korea hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 60 South Korea hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 61 Australia hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 62 Australia hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 63 Thailand hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 64 Thailand hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 65 Latin America hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 66 Latin America hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 67 Brazil hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 68 Brazil hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 69 Argentina hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 70 Argentina hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 71 Middle East & Africa hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 72 Middle East & Africa hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 73 South Africa hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 74 South Africa hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 75 Saudi Arabia hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 76 Saudi Arabia hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 77 UAE hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 79 UAE hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
Table 80 Kuwait hereditary testing market estimates & forecasts, by disease type, 2021-2033 (USD Million)
Table 81 Kuwait hereditary testing market estimates & forecasts, by technology, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Hereditary Testing Market Segmentation
Figure 8 Market Driver Relevance Analysis (Current & Future Impact)
Figure 9 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 10 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 11 Penetration & Growth Prospect Mapping
Figure 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration Vs Growth Prospect Mapping, 2024
Figure 15 Regional Marketplace: Key Takeaways
Figure 16 Regional Outlook, 2024 & 2033
Figure 17 North America Hereditary Testing Market, 2021-2033 (USD Million)
Figure 18 U.S. Hereditary Testing Market, 2021-2033 (USD Million)
Figure 19 Mexico Hereditary Testing Market, 2021-2033 (USD Million)
Figure 19 Canada Hereditary Testing Market, 2021-2033 (USD Million)
Figure 20 Europe Hereditary Testing Market, 2021-2033 (USD Million)
Figure 21 Germany Hereditary Testing Market, 2021-2033 (USD Million)
Figure 22 UK Hereditary Testing Market, 2021-2033 (USD Million)
Figure 23 France Hereditary Testing Market, 2021-2033 (USD Million)
Figure 24 Spain Hereditary Testing Market, 2021-2033 (USD Million)
Figure 25 Italy Hereditary Testing Market, 2021-2033 (USD Million)
Figure 26 Denmark Hereditary Testing Market, 2021-2033 (USD Million)
Figure 27 Sweden Hereditary Testing Market, 2021-2033 (USD Million)
Figure 28 Norway Hereditary Testing Market, 2021-2033 (USD Million)
Figure 29 Asia-Pacific Hereditary Testing Market, 2021-2033 (USD Million)
Figure 30 Japan Hereditary Testing Market, 2021-2033 (USD Million)
Figure 31 China Hereditary Testing Market, 2021-2033 (USD Million)
Figure 32 India Hereditary Testing Market, 2021-2033 (USD Million)
Figure 33 Australia Hereditary Testing Market, 2021-2033 (USD Million)
Figure 34 South Korea Hereditary Testing Market, 2021-2033 (USD Million)
Figure 35 Thailand Hereditary Testing Market, 2021-2033 (USD Million)
Figure 36 Latin America Hereditary Testing Market, 2021-2033 (USD Million)
Figure 37 Brazil Hereditary Testing Market, 2021-2033 (USD Million)
Figure 39 Argentina Hereditary Testing Market, 2021-2033 (USD Million)
Figure 40 Middle East and Africa Hereditary Testing Market, 2021-2033 (USD Million)
Figure 41 South Africa Hereditary Testing Market, 2021-2033 (USD Million)
Figure 42 Saudi Arabia Hereditary Testing Market, 2021-2033 (USD Million)
Figure 43 UAE Hereditary Testing Market, 2021-2033 (USD Million)
Figure 44 Kuwait Hereditary Testing Market, 2021-2033 (USD Million)
Figure 45 Global Hereditary Testing Market, for, Hereditary Cancer Testing 2021-2033 (USD Million)
Figure 46 Global Hereditary Testing Market, for, Lung Cancer 2021-2033 (USD Million)
Figure 47 Global Hereditary Testing Market, for, Breast Cancer 2021-2033 (USD Million)
Figure 48 Global Hereditary Testing Market, for, Colorectal Cancer 2021-2033 (USD Million)
Figure 49 Global Hereditary Testing Market, for, Cervical Cancer 2021-2033 (USD Million)
Figure 50 Global Hereditary Testing Market, for, Ovarian Cancer 2021-2033 (USD Million)
Figure 51 Global Hereditary Testing Market, for, Prostate Cancer 2021-2033 (USD Million)
Figure 52 Global Hereditary Testing Market, for, Stomach/Gastric Cancer 2021-2033 (USD Million)
Figure 53 Global Hereditary Testing Market, for, Melanoma 2021-2033 (USD Million)
Figure 54 Global Hereditary Testing Market, for, Sarcoma 2021-2033 (USD Million)
Figure 55 Global Hereditary Testing Market, for, Uterine Cancer 2021-2033 (USD Million)
Figure 56 Global Hereditary Testing Market, for, Pancreatic Cancer 2021-2033 (USD Million)
Figure 57 Global Hereditary Testing Market, for, Others 2021-2033 (USD Million)
Figure 58 Global Hereditary Testing Market, for, Genetic Tests 2021-2033 (USD Million)
Figure 59 Global Hereditary Testing Market, for, Cardiac Diseases 2021-2033 (USD Million)
Figure 60 Global Hereditary Testing Market, for, Rare Diseases 2021-2033 (USD Million)
Figure 61 Global Hereditary Testing Market, for, Other Diseases 2021-2033 (USD Million)
Figure 62 Global Hereditary Testing Market, for, Newborn Genetic Screening 2021-2033 (USD Million)
Figure 63 Global Hereditary Testing Market, for, Preimplantation Genetic Diagnosis & Screening 2021-2033 (USD Million)
Figure 64 Global Hereditary Testing Market, for, Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests 2021-2033 (USD Million)
Figure 65 Global Hereditary Testing Market, for, Cytogenetic 2021-2033 (USD Million)
Figure 66 Global Hereditary Testing Market, for, Biochemical 2021-2033 (USD Million)
Figure 67 Global Hereditary Testing Market, for, Molecular Testing 2021-2033 (USD Million)
